Nuclear uptake control of NF‐kappa B by MAD‐3, an I kappa B protein present in the nucleus.

I kappa B proteins specifically inhibit the DNA binding of NF‐kappa B/Rel transcription factors. An additional role as inhibitors of nuclear uptake was supposed by subcellular fractionation and enucleation experiments. Using indirect immunofluorescence labeling of cells, we show here that the DNA‐binding p50 and p65 subunits of NF‐kappa B, as well as the I kappa B protein MAD‐3, all occur in the nucleus when overexpressed on their own. Nuclear uptake of p65 and, to a lesser extent of p50, was, however, suppressed when MAD‐3 was coexpressed. Likewise, nuclear uptake of MAD‐3 was blocked by overexpressed p65 or p50. This directly demonstrates that I kappa B is a nuclear uptake regulatory protein and that the various subunits of NF‐kappa B can mutually control their access to the nucleus. In the presence of MAD‐3, antibodies specific for peptides overlapping the nuclear location signal (NLS) sequences of p65 and p50 could not recognize their epitopes on NF‐kappa B, suggesting that the I kappa B protein rendered the signals inaccessible for NLS receptors.

[1]  V. Bours,et al.  The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition , 1992, Nature.

[2]  C. Scheidereit,et al.  Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB , 1992, Nature.

[3]  D. Baltimore,et al.  The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. , 1992, The EMBO journal.

[4]  P. Dobrzanski,et al.  Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex , 1992, Molecular and cellular biology.

[5]  P. Morin,et al.  The C terminus of the NF-χB p50 precursor and an IχB isoform contain transcription activation domains , 1992 .

[6]  I. Verma,et al.  Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Ruben,et al.  I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity. , 1992, Genes & development.

[8]  R. Roeder,et al.  Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. , 1992, Genes & development.

[9]  A. Israël,et al.  NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats , 1992 .

[10]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[11]  Thomas Henkel,et al.  Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit , 1992, Cell.

[12]  C. Scheidereit,et al.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Bours,et al.  A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site , 1992, Molecular and cellular biology.

[14]  P. Dobrzanski,et al.  RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B , 1992, Molecular and cellular biology.

[15]  U. Zabel,et al.  Purified I kappa B-beta is inactivated upon dephosphorylation. , 1992, The Journal of biological chemistry.

[16]  U. Zabel,et al.  A novel complex between the p65 subunit of NF‐kappa B and c‐Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. , 1992, The EMBO journal.

[17]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.

[18]  A. Israël,et al.  Cytoplasmic retention, DNA binding and processing of the NF‐kappa B p50 precursor are controlled by a small region in its C‐terminus. , 1991, The EMBO journal.

[19]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[20]  M. Schmitz,et al.  Proteins controlling the nuclear uptake of NF-κB, Rel and dorsal , 1991 .

[21]  K. V. Van Zee,et al.  A hydrophobic protein sequence can override a nuclear localization signal independently of protein context , 1991, Molecular and cellular biology.

[22]  D. Baltimore,et al.  Rel-associated pp40: an inhibitor of the rel family of transcription factors. , 1991, Science.

[23]  Gary J. Nabel,et al.  Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65 , 1991, Nature.

[24]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[25]  I. Verma,et al.  The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. , 1991, Genes & development.

[26]  R. Lührmann,et al.  Nuclear import-export: In search of signals and mechanisms , 1991, Cell.

[27]  P. Baeuerle,et al.  NF‐kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. , 1991, The EMBO journal.

[28]  S. Haskill,et al.  Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity , 1991, Cell.

[29]  M. Rosenfeld,et al.  I-POU: a POU-domain protein that inhibits neuron-specific gene activation , 1991, Nature.

[30]  P. Baeuerle.  The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[31]  R. Steward,et al.  Dorsoventral pattern formation in Drosophila: signal transduction and nuclear targeting. , 1991, Trends in genetics : TIG.

[32]  S. Ruben,et al.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. , 1991, Science.

[33]  G. Nolan,et al.  DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide , 1991, Cell.

[34]  J. Auwerx,et al.  IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation , 1991, Cell.

[35]  J. Heitman,et al.  Nuclear protein localization. , 1991, Biochimica et biophysica acta.

[36]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[37]  P. Silver.  How proteins enter the nucleus , 1991, Cell.

[38]  C. Scheidereit,et al.  Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  U Zabel,et al.  DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. , 1991, The Journal of biological chemistry.

[40]  J. Habener,et al.  Cyclic‐AMP‐responsive transcriptional activation of CREB‐327 involves interdependent phosphorylated subdomains. , 1990, The EMBO journal.

[41]  Carl Wu,et al.  Molecular cloning and expression of a hexameric Drosophila heat shock factor subject to negative regulation , 1990, Cell.

[42]  P. Baeuerle,et al.  The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. , 1990, Genes & development.

[43]  T. Gilmore.  NF-κB, KBF1, dorsal, and related matters , 1990, Cell.

[44]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[45]  U. Zabel,et al.  Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA , 1990, Cell.

[46]  D. Baltimore,et al.  Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" , 1990, Nature.

[47]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[48]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[49]  D. Baltimore,et al.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. , 1989, Genes & development.

[50]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[51]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[52]  D. Baltimore,et al.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor , 1988, Cell.

[53]  H. Temin,et al.  v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells , 1988, Journal of virology.

[54]  D. Summers,et al.  Preparative elution of proteins blotted to Immobilon membranes. , 1988, Analytical biochemistry.

[55]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[56]  H. Temin,et al.  Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T , 1986, Cell.

[57]  Jna.  Note added in proof , 1980, The EMBO journal.

[58]  E. Fanning,et al.  Subclasses of simian virus 40 large T antigen: differential binding of two subclasses of T antigen from productively infected cells to viral and cellular DNA. , 1982, The EMBO journal.

[59]  D. Pim,et al.  Monoclonal antibodies specific for simian virus 40 tumor antigens , 1981, Journal of virology.

[60]  A. Graessmann,et al.  Microinjection of early SV40 DNA fragments and T antigen. , 1980, Methods in enzymology.

[61]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.